Services
Diagnoses
Procedures
A prostate cancer diagnosis presents several treatment pathways. The most appropriate option depends on factors such as the stage and aggressiveness of the cancer, overall health, and individual goals and preferences. Understanding these options helps patients make confident, informed decisions about their care.
Active Surveillance Active surveillance is commonly recommended for men with low-risk, slow-growing prostate cancer. This approach involves careful monitoring through regular PSA testing, digital rectal exams, and occasional biopsies. Treatment is only initiated if the cancer shows signs of progression, allowing many patients to avoid or delay side effects associated with active treatment.
Surgery (Prostatectomy) A prostatectomy involves the surgical removal of the prostate gland and is a common treatment for cancer confined to the prostate. Surgery may be performed using open, laparoscopic, or robotic-assisted techniques. This option is often recommended for otherwise healthy men with a longer life expectancy and aims to remove the cancer entirely.
Radiation Therapy Radiation therapy uses high-energy beams to destroy cancer cells. It may be delivered externally through external beam radiation therapy (EBRT) or internally through brachytherapy, in which radioactive seeds are placed within the prostate. Radiation is effective for localized prostate cancer and may also be used after surgery if there is concern about remaining cancer cells.
Hormone Therapy (Androgen Deprivation Therapy) Hormone therapy works by reducing levels of male hormones, or androgens, that stimulate prostate cancer growth. It is commonly used for advanced or recurrent prostate cancer and may be combined with other treatments, such as radiation therapy, to enhance effectiveness.
Chemotherapy Chemotherapy uses medications that target rapidly dividing cancer cells and is generally reserved for prostate cancer that has spread beyond the prostate or no longer responds to hormone therapy. It can help slow disease progression, manage symptoms, and improve quality of life in advanced cases.
Immunotherapy Immunotherapy strengthens the body’s immune response against cancer cells. Sipuleucel-T (Provenge) is an FDA-approved immunotherapy used primarily in advanced prostate cancer cases, particularly when other treatment options are no longer effective.
Targeted Therapy Targeted therapies focus on specific genetic changes that drive cancer growth. For example, PARP inhibitors may be used in patients whose prostate cancer is associated with BRCA1 or BRCA2 gene mutations.
Each treatment option carries its own benefits and potential risks. Patients are encouraged to discuss these options in detail with their healthcare provider to determine the most appropriate treatment plan based on cancer stage, overall health, potential side effects, and personal priorities.
843-884-8045